Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 10 EP applications Suzanne J. Baker has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 14, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13162452

Vaccine

IPC classification:
A61K 39/09, A61K 39/102, A61K 39/145, A61K 39/295, A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12720518

VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE

IPC classification:
A61K 39/09, A61P 31/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12721439

COMPOSITION COMPRISING A TLR AGONIST AND AN ANTIBODY SPECIFIC FOR AN ANTIGEN AND USES THEREOF AS VACCINE

IPC classification:
A61K 39/00, A61K 39/395, A61P 25/28
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13151470

Diamide Compounds having Muscarinic Receptor Antagonist and Beta 2 Adrenergic Receptor Agonist Activity

IPC classification:
A61K 31/444, A61P 11/00, A61P 11/08, C07D 401/12
Agent:
Suzanne J. Baker, GlaxoSmithKline
Agent:
Susan Margaret Scott, Abel & Imray
Status:
PATENT GRANTED
EP13710321

ADJUVANTED FORMULATIONS OF STREPTOCOCCUS PNEUMONIAE ANTIGENS

IPC classification:
A61K 31/4375, A61K 31/66, A61K 33/08, A61K 33/42, A61K 39/09, A61K 39/39
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP11706840

TREATMENT OF STREPTOCOCCAL INFECTIONS

IPC classification:
A61K 39/00, A61K 39/09, A61P 31/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Suzanne J. Baker, GlaxoSmithKline
Agent:
Suzanne J. Baker, GlaxoSmithKline Intellectual Property Management Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15195398

PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE

IPC classification:
A61K 39/09
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP15195408

VACCINE

IPC classification:
A61K 39/09, A61K 39/385
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15708341

USPA2 PROTEIN CONSTRUCTS AND USES THEREOF

IPC classification:
A61K 39/00, C07K 14/21, C07K 16/12
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16183732

PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE

IPC classification:
A61K 39/09
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature